FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
TECFIDERA
dimethyl fumarate
Peak
Biogen
ORAL · CAPSULE, DELAYED RELEASE
2013
NDA0/100
TECHNIVIE
ombitasvir; paritaprevir; ritonavir
Peak
AbbVie
ORAL · TABLET
2015
SMNDA0/100
TEGSEDI
inotersen sodium
Peak
SUBCUTANEOUS · SOLUTION
2018
NDA0/100
TEMBEXA
brincidofovir
Peak
Emergent BioSolutions
ORAL · SUSPENSION
2021
SMNDA0/100
TEMBEXA
brincidofovir
Peak
Emergent BioSolutions
ORAL · TABLET
2021
SMNDA0/100
TEPADINA
thiotepa
Peak
Adienne Pharma and Biotech
INTRACAVITARY, INTRAVENOUS, INTRAVESICAL · POWDER
2017
NDA0/100
TEPADINA AND SODIUM CHLORIDE
thiotepa
Peak
Adienne Pharma and Biotech
INTRAVENOUS · POWDER
2017
NDA0/100
TERLIVAZ
terlipressin
Peak
INTRAVENOUS · POWDER
2022
NDA0/100
THIOLA EC
tiopronin
Peak
Mission Pharmacal
ORAL · TABLET, DELAYED RELEASE
2019
NDA0/100
THYQUIDITY
levothyroxine sodium
Peak
ORAL · SOLUTION
2020
NDA0/100
TIBSOVO
ivosidenib
Peak
R-Pharm US
ORAL · TABLET
2018
SMNDA0/100
TIGECYCLINE
tigecycline
Peak
INTRAVENOUS · POWDER
2018
SMNDA0/100
TIROSINT-SOL
levothyroxine sodium
Peak
ORAL · SOLUTION
2016
NDA0/100
TLANDO
testosterone undecanoate
Peak
Verity Pharmaceuticals
ORAL · CAPSULE
2022
NDA0/100
TOLSURA
itraconazole
Peak
ORAL · CAPSULE
2018
SMNDA0/100
TORISEL
temsirolimus
Peak
Pfizer
INTRAVENOUS · SOLUTION
2007
NDA0/100
TOSYMRA
sumatriptan
Peak
NASAL · SPRAY
2019
NDA0/100
TPOXX
tecovirimat monohydrate
Peak
Siga
ORAL · CAPSULE
2018
NDA0/100
TPOXX
tecovirimat monohydrate
Peak
Siga
INTRAVENOUS · SOLUTION
2022
NDA0/100
TRADJENTA
linagliptin
Peak
Boehringer Ingelheim
ORAL · TABLET
2011
SMNDA0/100
TRALEMENT
trace elements injection 4
Peak
INTRAVENOUS · SOLUTION
2020
NDA0/100
TREANDA
bendamustine hydrochloride
Peak
Teva
INTRAVENOUS · SOLUTION
2008
NDA0/100
TRELEGY ELLIPTA
fluticasone furoate, umeclidinium bromide and vilanterol trifenatate
Peak
GSK
INHALATION · POWDER
chronic obstructive pulmonary diseaseCOPD+1
2017
NDA0/100
TRIJARDY XR
empagliflozin, linagliptin, metformin hydrochloride
Peak
Boehringer Ingelheim
ORAL · TABLET, EXTENDED RELEASE
2020
NDA0/100